Navigation Links
Rat Frozen Reproductive Tissue Microarray from Zyagen Laboratories

ProductsRat Frozen Reproductive Tissue Microarray from Zyagen Laboratories
Company Zyagen Laboratories
Item Rat Frozen Reproductive Tissue Microarray
Price $310.00
Description Zyagen tissue microarrays are derived from frozen embedded tissue blocks, which are subjected to rigorous quality control procedures to ensure the highest quality. Tissues of each array are manually assembled in one block, sectioned at a thickness of 7 microns and mounted on coated slides. Sections are large (3-5 mm in diameter) in comparison to core sections made using Tissue Arrayer. Arrays enable high throughput screening of large number of tissue specimens by immunohistochemistry and in situ hybridization.

Tissues: Testis, Epididymis caput, Epididymis corpus, Epididymis cauda, Ductus deferens, Seminal vesicles, Prostate, Ovary & Oviduct, Uterus, Vagina
Info Zyagen LaboratoriesZyagen Laboratories
10225 Barnes Canyon Road
San Diego, CA 92121
Customer Service: 858-442-0704
Fax Number: 858-546-0736
Web Site: http://www.zyagen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Frozen-EZ Yeast Transformation II Kit from Zymo Research
2. Mouse Frozen Reproductive Tissue Microarray from Zyagen Laboratories
3. Mouse Frozen Mixed Tissue Microarray, Panel -3 from Zyagen Laboratories
4. Mouse Frozen Neuronal Tissue Microarray from Zyagen Laboratories
5. Mouse Frozen Digestive Tissue Microarray from Zyagen Laboratories
6. Rat Frozen Neuronal Tissue Microarray from Zyagen Laboratories
7. Rat Frozen Mixed Tissue Microarray, Panel- 2 from Zyagen Laboratories
8. Sf9 Frozen Cells (Graces Media) from Invitrogen
9. Sf21 Frozen Cells (Graces Media) from Invitrogen
10. Frozen Tissue Section Panel - Monkey (Cynomolgus) Normal Tissue, Multi-tissue I from BioChain
11. Frozen Tissue Section Panel - Monkey (Rhesus) Normal Tissue, Multi-tissue I from BioChain
96 Well Base Plate...
... Recombinant Ribonuclease Inhibitor is a ... ribonucleases such as RNase A. ... Recombinant Ribonuclease Inhibitor is an ... weight ~52 kDa. RNaseOUT inhibits ...
... and Recombinant RNasin Ribonuclease Inhibitors have broad ... of eukaryotic RNases of the neutral type ... effect by noncovalently binding to RNases in ... the binding of RNasin Ribonuclease Inhibitor to ...
UGT1A7 (E-15)...
Biology Products:
(Date:8/20/2014)... Ore. -- When are athletes who have suffered concussions ... Oregon study has found that high school athletes who ... 60 days experience a significant regression in their abilities ... The regression, as seen in changes in their balance ... 19 athletes. Ten of the 12 had returned to ...
(Date:8/20/2014)... a burning spiciness that is irresistible to some, but ... are using their findings to develop a new drug ... caused by inflammation or other problems. They reported their ... clinical trials, in ACS, Journal of Medicinal Chemistry ... ago, scientists had pegged a compound called capsaicin as ...
(Date:8/20/2014)... chairs, synthetic rugs and plastic bags could one day ... rather than petroleum, scientists are now reporting. The novel ... the world deal with its agricultural and plastic waste ... , Athanassia Athanassiou, Ilker S. Bayer and colleagues at ... popularity is constantly growing. In 2012, its production reached ...
Breaking Biology News(10 mins):Recovery reversal seen in Oregon study of returning concussed athletes 2Recovery reversal seen in Oregon study of returning concussed athletes 3
... Today,s opening of a new breast health center next ... significant research opportunities for the Translational Genomics Research Institute ... will include a tumor biorepository for TGen that will ... to diagnose and treat breast cancer, which affects 1 ...
... the results are receiving rave reviews from apple lovers. ... a new apple cultivar has been introduced by scientists ... New Jersey, and Indiana experiment stations. This high-quality dessert ... S. Korban, of the Department of Natural Resources and ...
... GREECETo grow the high-quality potted plants preferred by ... affect plant growth and development. The use of ... production of compact gardenia plants; the chemicals are ... the production of lateral shoots that create aesthetically ...
Cached Biology News:Breast health center gives TGen new research opportunities 2Apple enthusiasts welcome WineCrisp 2Photoselective film proves effective for controlling height in potted gardenia plants 2
(Date:8/20/2014)... , Aug. 20, 2014 Clintrax ... services located in Raleigh, NC ... Evans as Vice President of Administration. ... will oversee all corporate processes, including their alignment ... Clintrax Global, Brad worked as an HR executive, ...
(Date:8/20/2014)... often have it that American Indians largely were wiped ... influenza and tuberculosis brought to the New World by ... 20 million people lived in the Americas shortly before ... killed by European diseases., But new research led by ... Johannes Krause of the University of Tubingen in Germany ...
(Date:8/20/2014)... Neurotrope, Inc. (OTCQB: NTRP) today announced ... provide an update on Company activities. Access information:Date:Tuesday, ... 505-4369 (U.S. and Canada) or (719) 325-2315 Conference ... under "Investor Relations"The teleconference replay will be available ... 2014 at (888) 203-1112 (U.S. and ...
(Date:8/20/2014)... 2014  Decision Resources Group finds that the vascular access device ... , India and China ... equal to the size of the United States ... experience much faster growth as a result of strong economic expansion, ... key findings from Decision Resources Group,s coverage of the BRIC vascular ...
Breaking Biology Technology:Clintrax Global, Inc. Announces Addition to Executive Team 2Unusual discovery leads to fascinating tuberculosis theory 2Unusual discovery leads to fascinating tuberculosis theory 3Neurotrope To Host Conference Call 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3